Literature DB >> 2048880

[Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS].

T Saint-Marc, L Rossello-Prats, J L Touraine.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2048880

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN： 0003-410X


× No keyword cloud information.
  17 in total

Review 1.  Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives.

Authors:  Jean-Paul Buts
Journal:  Dig Dis Sci       Date:  2008-06-05       Impact factor: 3.199

Review 2.  Risk and safety of probiotics.

Authors:  Shira Doron; David R Snydman
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

Review 3.  Effects of Saccharomyces boulardii on intestinal mucosa.

Authors:  Jean-Paul Buts; Nadine De Keyser
Journal:  Dig Dis Sci       Date:  2006-07-13       Impact factor: 3.199

4.  Saccharomyces boulardii inhibits water and electrolytes changes induced by castor oil in the rat colon.

Authors:  Philippe Girard; Yannick Pansart; Marie-Claude Coppe; Jean-Marie Gillardin
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

Review 5.  Probiotics for treating acute infectious diarrhoea.

Authors:  Stephen J Allen; Elizabeth G Martinez; Germana V Gregorio; Leonila F Dans
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

Review 6.  Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis.

Authors:  Aloysius L D'Souza; Chakravarthi Rajkumar; Jonathan Cooke; Christopher J Bulpitt
Journal:  BMJ       Date:  2002-06-08

Review 7.  Probiotics in infectious diarrhoea in children: are they indicated?

Authors:  Y Vandenplas; S Salvatore; M Vieira; M Viera; T Devreker; B Hauser
Journal:  Eur J Pediatr       Date:  2007-07-05       Impact factor: 3.183

8.  The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea.

Authors:  Atakan Sezer; Ufuk Usta; Irfan Cicin
Journal:  Med Oncol       Date:  2008-12-09       Impact factor: 3.064

9.  Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

Authors:  Theodoros Kelesidis; Charalabos Pothoulakis
Journal:  Therap Adv Gastroenterol       Date:  2012-03       Impact factor: 4.802

10.  Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation.

Authors:  Anna Murzyn; Anna Krasowska; Piotr Stefanowicz; Dorota Dziadkowiec; Marcin Łukaszewicz
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.